Matthew discusses the complexities of sector selection, particularly within healthcare, highlighting the contrasting performance of biotech during economic downturns. He emphasizes a multifaceted approach to investment, incorporating both technical momentum strategies and fundamental analysis. Current valuation metrics suggest that financials and energy sectors are among the most undervalued, presenting potential opportunities for investors.
